2Liavaag AH, Do rum A, Fossa SD, et al. A cont rolled study of fatigue, quality of life, somatic and mental morbidity in epithelial ovarian cancer survivors: How lucky are the lucky ones? J Clin Oncol, 2007, 25 (15): 2049-2056. 被引量：1
3Chi DS, Liao JB, Leon LF, et al. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol, 2001,82 (3): 532-537. 被引量：1
5Tangjitgamol S, Manusirivithaya S, Laopaiboon M, et al. Interval debulking surgery for advanced epithelial ovarian cancer: a Cochrane systematic review. Gynecol Oncol, 2009,112: 257-264. 被引量：1
6Muggia F. Platinum compounds 30 years after the introduction of cisplatm: implications for the treatment of ovarian cancer. GynecolOncol, 2009, 112: 275-281. 被引量：1
8Lentz SS, Miller BE, Kucera GL, et al. Intraperitoneal hyperthermic chemotherapy using carboplatin: A phase I analysis in ovarian carcinoma. Gvnecol Oncol. 2007.106 (1): 207-210. 被引量：1
9Bijelic L, Jonson A, Sugarbaker PH. Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol, 2007,18 (12): 1943-1950. 被引量：1
